Mary Fisher
CIK: 0001272360
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dermata Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 2, 2026DRMA
Dermata Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
2.5K shares- - Jan 21, 2025DRMA
Dermata Therapeutics, Inc.
Award(A)Direct196.9K shares- - Jan 13, 2025DRMA
Dermata Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
5K shares-
1-3 of 3 transactions
About FISHER MARY
FISHER MARY (SEC CIK 0001272360) files insider reports with the SEC as Director of Dermata Therapeutics, Inc. (DRMA).
Signal8 holds 3 ownership filings by FISHER MARY, all Form 4s, filed between Jan 14, 2025 and Jan 6, 2026. Those filings report 3 transactions, from Jan 13, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on FISHER MARY's filings is in SAN DIEGO, CA.
Recent filings by FISHER MARY
Other insiders filing for Dermata Therapeutics, Inc. (DRMA)
- PROEHL GERALD T, PRESIDENT, CHAIRMAN, CEO
- Van Hoose Kyri K., SVP, CFO
- Scott Kathleen D., Director
- Bedoya-Toro Munera Maria E, SVP, Regulatory Affairs
- WIERENGA WENDELL, Director
- HALE DAVID F, Director